U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9804198041Evaluation of Methods to Asses Visual Prosthesis Systems Using Sighted Volunteers and Visual Reality SimulatorRecruitingNo Results AvailableFocus of Study: Finding Ways to Evaluate Visual Prosthesis Systemshttps://ClinicalTrials.gov/show/NCT01282489
9804298042Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell LymphomaActive, not recruitingNo Results AvailableDiffuse Large B Cell LymphomaDrug: Panobinostat with Rituximabhttps://ClinicalTrials.gov/show/NCT01282476
9804398043Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaCompletedNo Results AvailableCarcinoma of Urinary Tract|Urethral Carcinoma|Carcinoma of Ureter|Carcinoma of Renal PelvisDrug: Docetaxel|Biological: Ramucirumab DP|Biological: IMC-18F1https://ClinicalTrials.gov/show/NCT01282463
9804498044Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableStage IV (Oligo-metastases)|Non-small Cell Lung CancerRadiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT01282450
9804598045Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLCCompletedNo Results AvailableNon Small Cell Lung Cancer (NSCLC)|Radical Treatment|Stage III Non-Small Cell Lung CancerRadiation: Prophylactic Cranial Irradiationhttps://ClinicalTrials.gov/show/NCT01282437
9804698046Efficacy and Safety Study of Idelalisib in Subjects With Indolent B-Cell Non-Hodgkin LymphomaActive, not recruitingHas ResultsFollicular Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma|Marginal Zone LymphomaDrug: Idelalisibhttps://ClinicalTrials.gov/show/NCT01282424
9804798047Anatomic Outcomes Following Ozurdex InjectionsRecruitingNo Results AvailableRetinal Vein Occlusionshttps://ClinicalTrials.gov/show/NCT01282411
9804898048Study About Simvastatin in Portal Hypertension in Compensated CirrhosisNot yet recruitingNo Results AvailablePortal Hypertension.|Liver CirrhosisDrug: Simvastatin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01282398
9804998049Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal HypertensionNot yet recruitingNo Results AvailableLiver Cirrhosis|Portal Hypertension.Drug: Simvastatin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01282385
9805098050Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedHas ResultsRheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritishttps://ClinicalTrials.gov/show/NCT01282372
9805198051Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations PreventionCompletedNo Results AvailableAsthmaOther: Clinical practice group|Other: "Gold Standard" educational group|Other: Intervention grouphttps://ClinicalTrials.gov/show/NCT01282359
9805298052SOLX Gold Shunt for Refractory GlaucomaActive, not recruitingNo Results AvailableGlaucoma|Glaucoma, Open AngleDevice: SOLX Gold Shunthttps://ClinicalTrials.gov/show/NCT01282346
9805398053Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNo Results AvailableAdvanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage III PaDrug: gemcitabine hydrochloride|Drug: veliparib|Other: diagnostic laboratory biomarker analysis|Other: pharmacological study|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT01282333
9805498054WHAT (Women, Hot-flashes, Activity, Trial) - Physical Activity for Treatment of Hot Flushes Among Postmenopausal WomenActive, not recruitingNo Results AvailablePostmenopausal Symptoms|Hot FlashesBehavioral: Physical activity intervention programhttps://ClinicalTrials.gov/show/NCT01282320
9805598055Improving Insight in Patients Diagnosed With SchizophreniaCompletedNo Results AvailableSchizophreniaBehavioral: Guided Self-Determination GSDhttps://ClinicalTrials.gov/show/NCT01282307
9805698056Clinical Follow-up to Evaluate the Clinical Usefulness of Gentamicin-coated Titanium Nails in Tibia FracturesCompletedHas ResultsTibia FracturesDevice: ETN PROtecthttps://ClinicalTrials.gov/show/NCT01282294
9805798057Prospective Metabolic Monitoring of Youth and Adults With Bipolar DisorderCompletedNo Results AvailableBipolar Disorder|Youth|Adultshttps://ClinicalTrials.gov/show/NCT01282281
9805898058Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X SyndromeCompletedNo Results AvailableFragile X SyndromeDrug: arbaclofen|Drug: placebohttps://ClinicalTrials.gov/show/NCT01282268
9805998059Efficacy of NNC109-0012 in Subjects With Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid Arthritis|InflammationDrug: NNC109-0012|Drug: placebohttps://ClinicalTrials.gov/show/NCT01282255
9806098060MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected PatientsRecruitingNo Results AvailableAcute StrokeDrug: IV rt-PAhttps://ClinicalTrials.gov/show/NCT01282242
9806198061Study to Compare Laser Assisted New Attachment Procedure (LANAP) to Traditional Treatments of Chronic PeriodontitisActive, not recruitingNo Results AvailableChronic PeriodontitisDevice: LANAPhttps://ClinicalTrials.gov/show/NCT01282229
9806298062Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant CyclophosphamideRecruitingNo Results AvailableTransplant-Related CancerBiological: Hepatitis A|Biological: PCV 13https://ClinicalTrials.gov/show/NCT01282216
9806398063Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical PracticeCompletedHas ResultsAnesthesia, Generalhttps://ClinicalTrials.gov/show/NCT01282203
9806498064Effectiveness of Motivational Interview in Patients With DyslipidemiaCompletedNo Results AvailablePatients With DyslipidemiaBehavioral: Motivational interviewhttps://ClinicalTrials.gov/show/NCT01282190
9806598065Influenza Vaccine Safety and Effectiveness in Healthcare ProvidersSuspendedNo Results AvailableInfluenzahttps://ClinicalTrials.gov/show/NCT01282177
9806698066The Diagnostic Accuracy of the Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and the Hypothalamic-Pituitary-Adrenal AxisActive, not recruitingNo Results AvailableAdult Growth Hormone Deficiency|Hypothalamic-pituitary DisordersProcedure: Glucagon stimulation test and insulin tolerance test|Procedure: glucagon stimulation test and insulin tolerance testhttps://ClinicalTrials.gov/show/NCT01282164
9806798067TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung CancerTerminatedNo Results AvailableCarcinoma, Non Small Cell LungDrug: Taxotere|Drug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT01282151
9806898068Assessment of Alcon's Ocular Image Quantification SystemCompletedHas ResultsAllergic ConjunctivitisDrug: Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)|Other: Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)https://ClinicalTrials.gov/show/NCT01282138
9806998069Nasal Obstruction in Sleep Apnea Patients Compared to the General PopulationRecruitingNo Results AvailableObstructive Sleep Apnoea Syndrome|Nasal Obstructionhttps://ClinicalTrials.gov/show/NCT01282125
9807098070Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous PentobarbitalCompletedNo Results AvailableChildrens 0 to 18 Years of Age Who Require Moderate Sedationhttps://ClinicalTrials.gov/show/NCT01282112

* Görseller ve İçerik tekif hakkına sahip olabilir